NCT06204848

Brief Summary

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

November 12, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

September 17, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

January 3, 2024

Last Update Submit

September 15, 2025

Conditions

FloatersVitreous Opacities

Outcome Measures

Primary Outcomes (1)

  • Successful capture of SLO and OCT imaging data of SVOs for algorithm development

    Successful collection of SLO and OCT imaging data

    Through study completion, an average of 6-8 months

Secondary Outcomes (1)

  • Collection of patient-reported symptoms

    Through study completion, an average of 6-8 months

Study Arms (1)

Imaging using the SVO-ID

EXPERIMENTAL

Patients will have their eyes imaged with the SVO-ID as part of a study visit.

Device: SVO-ID

Interventions

SVO-IDDEVICE

Combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for imaging of the eye

Imaging using the SVO-ID

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Symptomatic vitreous opacities (floaters) in vision
  • Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

You may not qualify if:

  • Younger than 18 years of age
  • Presence of vitreous hemorrhage
  • Cataract Grade 3 and above
  • Opacification of lens, cornea, or vitreous
  • Diagnosis of narrow angle glaucoma
  • Refractive error is outside the range of -6D to+3D
  • Astigmatism is outside the range of +/-2D of cylinder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alberta Retina Consultants

Edmonton, Alberta, T5H 0X5, Canada

Location

MeSH Terms

Conditions

vitreous floaters

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 12, 2024

Study Start

November 12, 2024

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

September 17, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations

CA(1)